|
RNF216 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66290000003233E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.224900E-03 |
| Normal-vs-Stage2 |
3.751600E-02 |
| Normal-vs-Stage3 |
1.409710E-02 |
| Normal-vs-Stage4 |
4.487200E-01 |
| Stage1-vs-Stage2 |
6.763200E-01 |
| Stage1-vs-Stage3 |
6.763200E-01 |
| Stage1-vs-Stage4 |
6.503800E-01 |
| Stage2-vs-Stage3 |
9.520200E-01 |
| Stage2-vs-Stage4 |
4.065600E-01 |
| Stage3-vs-Stage4 |
3.973800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.011700E-04 |
| Normal-vs-AfricanAmerican |
1.724640E-03 |
| Normal-vs-Asian |
5.652800E-01 |
| Caucasian-vs-AfricanAmerican |
3.504200E-01 |
| Caucasian-vs-Asian |
9.143400E-01 |
| AfricanAmerican-vs-Asian |
6.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.970500E-04 |
| Normal-vs-Female |
2.35469999999571E-05 |
| Male-vs-Female |
6.265700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.622630E-01 |
| Normal-vs-Extreme_Weight |
6.698800E-03 |
| Normal-vs-Obese |
2.192100E-04 |
| Normal-vs-Extreme_Obese |
1.965770E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.501000E-01 |
| Normal_Weight-vs-Obese |
2.297800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.014000E-01 |
| Extreme_Weight-vs-Obese |
7.442400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.504000E-01 |
| Obese-vs-Extreme_Obese |
6.977000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.799400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.01080000042475E-07 |
| Normal-vs-Age(61-80Yrs) |
4.134400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.714800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.958400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.523640E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.466210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.736100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.179600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.465800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.15830000538375E-08 |
| Normal-VS-Type2 PRCC |
7.615000E-01 |
| Normal-VS-KIRP CIMP |
3.329700E-02 |
| Normal-VS-Unclassified PRCC |
8.898800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.68960000000085E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.715000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.721600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.902600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.058000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.620800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.303800E-01 |
| Normal-vs-N1 |
1.777880E-02 |
| Normal-vs-N2 |
7.082700E-03 |
| N0-vs-N1 |
6.356000E-02 |
| N0-vs-N2 |
3.315600E-01 |
| N1-vs-N2 |
9.963800E-01 |
|
|
